Titlebook: Gender Differences in the Pathogenesis and Management of Heart Disease; Jawahar L. Mehta,Jean McSweeney Book 2018 Springer International P

請回避

書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease影響因子(影響力)




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease影響因子(影響力)學科排名




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease網(wǎng)絡公開度




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease網(wǎng)絡公開度學科排名




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease被引頻次




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease被引頻次學科排名




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease年度引用




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease年度引用學科排名




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease讀者反饋




書目名稱Gender Differences in the Pathogenesis and Management of Heart Disease讀者反饋學科排名

Longitude

Atherosclerosis and Gender-Related Differences,n men and women. Other studies have shown that women as compared to men have poorer prognosis after STEMI and CABG. An improved understanding the gender related pathophysiology will help in improved management of CAD in women.

他很靈活

Sex-Based Differences in Risk Determinants and Management of Heart Failure,both sexes. Current treatment guidelines are not sex-specific because sufficient data is not available, however, as the therapeutic options for HF expand, sex-based modifications to HF management may be considered in future revisions.

coltish

壓迫

Angina and Ischemia in Women with No Obstructive Coronary Artery Disease,of myocardial ischemia. CMD is associated with adverse cardiovascular outcomes, including myocardial infarction, stroke, and heart failure. This chapter focuses on CMD diagnosis and treatment (pharmacological and non-pharmacological approaches) in women with no obstructive CAD.

NAUT

Sex-Specific Differences in Acute Myocardial Infarction,th AMI remain under-recognized and under-treated by the current health care system, despite increasing awareness and advancement in women’s cardiovascular health. This chapter will discuss known and emerging gender differences in pathophysiology, risk factors, clinical presentation, diagnosis, and m

NAUT

The Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women, of sex-specific outcomes data precludes the implementation of evidence-based interventions into clinical practice. More recently, emerging data on non-traditional risk factors unique to and/or more commonly found in women is also shedding new light on the increased burden of disease among younger w

周興旺

Infinitesimal

Gender Differences in Cardiovascular Drugs,rences in the responses to common cardiovascular drugs including statins, antiplatelet and antithrombotic agents, β-blockers, digoxin, calcium channel blockers, isosorbide mononitrate, aldosterone antagonists, and drugs associated with the long QT syndrome.

ellagic-acid